Stock listing
DMRA Stock Price, News, Filings & Events — Damora Therapeutics, Inc.
Selected listing: DMRA · BOATS · USD · US
This page tracks Damora Therapeutics, Inc.'s DMRA:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following DMRA:BOATS. DMRA:BOATS is the stock-level entry point for investors researching Damora Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Damora Therapeutics, Inc. is a public company traded under the ticker DMRA in the American market. With a market capitalization of approximately $1.77 billion, the company focuses on developing innovative therapeutic solutions. Its commitment to advancing healthcare is reflected in its strategic initiatives and research efforts.

- Ticker
- DMRA:BOATS
- Asset type
- Stock
- Market cap
- $1.86B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BOATS
- Currency
- USD
Damora Therapeutics, Inc. DMRA:BOATS stock context
This page tracks Damora Therapeutics, Inc.'s DMRA:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following DMRA:BOATS. DMRA:BOATS is the stock-level entry point for investors researching Damora Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Damora Therapeutics, Inc. is a public company traded under the ticker DMRA in the American market. With a market capitalization of approximately $1.77 billion, the company focuses on developing innovative therapeutic solutions. Its commitment to advancing healthcare is reflected in its strategic initiatives and research efforts.
Latest news from Damora Therapeutics, Inc.
Damora Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
August 10, 2026
Damora Announces Redomestication from Delaware to Cayman Islands
July 17, 2026
Damora Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
May 12, 2026
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)
May 4, 2026
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 30, 2026
Research Damora Therapeutics, Inc.
Damora Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for DMRA:BOATS.
Damora Therapeutics, Inc. company profile
View the public company page for Damora Therapeutics, Inc. on 6ix.
Damora Therapeutics, Inc. news
Read company news and market updates connected to Damora Therapeutics, Inc..
Damora Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Damora Therapeutics, Inc..